Structure via PubChem · Public domain (PubChem)
forodesina
Sign in to saveAlso known as BCX-1777, BCX1777, Fodosine® (proposed trade name), immucillin H, immucillin-H, (2R,3R,4S,5S)-2-(hydroxymethyl)-5-(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidine-3,4-diol, Forodesine, (1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol
composto chimico
In the Vinony graph
Vinony's link graph records 5 inbound references to forodesina, and connects out to digital object identifier, chemical formula and molar mass.
It is catalogued under topics including Chemical pages without DrugBank identifier, Drugs missing an ATC code and Drugs with no legal status.
Vinony links it to 8 Wikipedia language editions.
Chemical data
- Formula
- C11H14N4O4
- Molecular weight
- 266.25 g/mol
- IUPAC name
- 7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one
- SMILES
- C1=C(C2=C(N1)C(=O)N=CN2)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
- InChIKey
- IWKXDMQDITUYRK-KUBHLMPHSA-N
- XLogP
- -2.3
- Polar surface area
- 130 Ų
- H-bond donors
- 6
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2017
- Indications
- B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, leukemia, lymphoma
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 266.102
Show 4 more facts
- chemical formula
- C₁₁H₁₄N₄O₄
- isomeric SMILES
- C1=C(C2=C(N1)C(=O)N=CN2)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
- canonical SMILES
- C1=C(C2=C(N1)C(=O)N=CN2)C3C(C(C(N3)CO)O)O
- Commons category
- Immucillin H
Sources (2)
via Wikidata · CC0
Article · Italiano
Forodesina è un farmaco inibitore analogo allo stato di transizione per la fosforilasi dei nucleosidi purinici, studiata per il trattamento di pazienti con leucemia linfoblastica acuta a cellule T (T-ALL) e a cellule B (B-ALL). Originariamente fu scoperta dal laboratorio di presso l'Albert Einstein College of Medicine di New York e Industrial Research Limited in Nuova Zelanda. Viene sviluppata dalla casa farmaceutica e progettata per essere un potente ed efficace citocida nei confronti di cellule neoplastiche ed ha mostrato un’attività clinica positiva in pazienti con recidiva / refrattaria di neoplasia delle cellule T.
Abstract from DBpedia / Wikipedia · CC BY-SA